225 related articles for article (PubMed ID: 19603830)
1. Amyloid fibrillation of human Apaf-1 CARD.
Rao PN; Reddy KS; Bhuyan AK
Biochemistry; 2009 Aug; 48(32):7656-64. PubMed ID: 19603830
[TBL] [Abstract][Full Text] [Related]
2. Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation.
Kumar S; Udgaonkar JB
J Mol Biol; 2009 Jan; 385(4):1266-76. PubMed ID: 19063899
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
Kumar S; Mohanty SK; Udgaonkar JB
J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
[TBL] [Abstract][Full Text] [Related]
4. Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology.
Zerovnik E; Skarabot M; Skerget K; Giannini S; Stoka V; Jenko-Kokalj S; Staniforth RA
Amyloid; 2007 Sep; 14(3):237-47. PubMed ID: 17701471
[TBL] [Abstract][Full Text] [Related]
5. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
[TBL] [Abstract][Full Text] [Related]
6. Rapid folding and unfolding of Apaf-1 CARD.
Milam SL; Nicely NI; Feeney B; Mattos C; Clark AC
J Mol Biol; 2007 May; 369(1):290-304. PubMed ID: 17408690
[TBL] [Abstract][Full Text] [Related]
7. A single mutation induces amyloid aggregation in the alpha-spectrin SH3 domain: analysis of the early stages of fibril formation.
Morel B; Casares S; Conejero-Lara F
J Mol Biol; 2006 Feb; 356(2):453-68. PubMed ID: 16375922
[TBL] [Abstract][Full Text] [Related]
8. Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties.
Malisauskas M; Weise C; Yanamandra K; Wolf-Watz M; Morozova-Roche L
J Mol Biol; 2010 Feb; 396(1):60-74. PubMed ID: 19913026
[TBL] [Abstract][Full Text] [Related]
9. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module.
Litvinovich SV; Brew SA; Aota S; Akiyama SK; Haudenschild C; Ingham KC
J Mol Biol; 1998 Jul; 280(2):245-58. PubMed ID: 9654449
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling.
Vaughn DE; Rodriguez J; Lazebnik Y; Joshua-Tor L
J Mol Biol; 1999 Oct; 293(3):439-47. PubMed ID: 10543941
[TBL] [Abstract][Full Text] [Related]
11. Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation.
Bader R; Bamford R; Zurdo J; Luisi BF; Dobson CM
J Mol Biol; 2006 Feb; 356(1):189-208. PubMed ID: 16364365
[TBL] [Abstract][Full Text] [Related]
12. Oleic acid inhibits amyloid formation of the intermediate of alpha-lactalbumin at moderately acidic pH.
Yang F; Zhang M; Zhou BR; Chen J; Liang Y
J Mol Biol; 2006 Sep; 362(4):821-34. PubMed ID: 16935298
[TBL] [Abstract][Full Text] [Related]
13. Amyloid fibril formation by the CAD domain of caspase-activated DNase.
Uegaki K; Nakamura T; Yamamoto H; Kobayashi A; Odahara T; Harata K; Hagihara Y; Ueyama N; Yamazaki T; Yumoto N
Biopolymers; 2005 Sep; 79(1):39-47. PubMed ID: 15940676
[TBL] [Abstract][Full Text] [Related]
14. Fibril formation of hsp10 homologue proteins and determination of fibril core regions: differences in fibril core regions dependent on subtle differences in amino acid sequence.
Yagi H; Sato A; Yoshida A; Hattori Y; Hara M; Shimamura J; Sakane I; Hongo K; Mizobata T; Kawata Y
J Mol Biol; 2008 Apr; 377(5):1593-606. PubMed ID: 18329043
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-like fibril formation of co-chaperonin GroES: nucleation and extension prefer different degrees of molecular compactness.
Higurashi T; Yagi H; Mizobata T; Kawata Y
J Mol Biol; 2005 Sep; 351(5):1057-69. PubMed ID: 16054644
[TBL] [Abstract][Full Text] [Related]
16. Amyloid fibril formation by human stefin B in vitro: immunogold labelling and comparison to stefin A.
Zerovnik E; Zavasnik-Bergant V; Kopitar-Jerala N; Pompe-Novak M; Skarabot M; Goldie K; Ravnikar M; Musevic I; Turk V
Biol Chem; 2002 May; 383(5):859-63. PubMed ID: 12108553
[TBL] [Abstract][Full Text] [Related]
17. Multiple assembly pathways underlie amyloid-beta fibril polymorphisms.
Goldsbury C; Frey P; Olivieri V; Aebi U; Müller SA
J Mol Biol; 2005 Sep; 352(2):282-98. PubMed ID: 16095615
[TBL] [Abstract][Full Text] [Related]
18. Additional supra-self-assembly of human serum albumin under amyloid-like-forming solution conditions.
Juárez J; Taboada P; Goy-López S; Cambón A; Madec MB; Yeates SG; Mosquera V
J Phys Chem B; 2009 Sep; 113(36):12391-9. PubMed ID: 19681594
[TBL] [Abstract][Full Text] [Related]
19. Effect of curcumin on amyloidogenic property of molten globule-like intermediate state of 2,5-diketo-D-gluconate reductase A.
Sarkar N; Singh AN; Dubey VK
Biol Chem; 2009 Oct; 390(10):1057-61. PubMed ID: 19558331
[TBL] [Abstract][Full Text] [Related]
20. Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways.
Morozova-Roche LA; Zamotin V; Malisauskas M; Ohman A; Chertkova R; Lavrikova MA; Kostanyan IA; Dolgikh DA; Kirpichnikov MP
Biochemistry; 2004 Aug; 43(30):9610-9. PubMed ID: 15274615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]